{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:36:41Z","timestamp":1791110201797,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1124\/dmd.31.4.421","type":"journal-article","created":{"date-parts":[[2003,3,18]],"date-time":"2003-03-18T11:14:00Z","timestamp":1047986040000},"page":"421-431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":287,"title":["Effects of Prototypical Microsomal Enzyme Inducers on Cytochrome P450 Expression in Cultured Human Hepatocytes"],"prefix":"10.1016","volume":"31","author":[{"given":"Ajay","family":"Madan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Mudra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Alayne","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April D.","family":"Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Czerwinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jameson","family":"Forster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria D.","family":"Ribadeneira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Shang","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"LeCluyse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Zech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Philmore","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lida","family":"Antonian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Parkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.31.4.421_bib1","series-title":"Metabolic Drug Interactions","first-page":"673","article-title":"Drugs as inducers of metabolic enzymes: phenobarbital, phenytoin and carbamazepine","author":"Abdel-Rahman","year":"2000"},{"key":"10.1124\/dmd.31.4.421_bib2","first-page":"1074","article-title":"The use of a high-volume screening procedure to assess the effects of dietary flavonoids on human cyp1a1 expression.","volume":"29","author":"Allen","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.4.421_bib3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0090-9556(25)06652-8","article-title":"Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.","volume":"23","author":"Bullock","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.4.421_bib4","first-page":"1946","article-title":"Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines.","volume":"57","author":"Chang","year":"1997","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.31.4.421_bib5","first-page":"1165","article-title":"Pharmacokinetic consequences of induction of CYP2E1 by ligand stabilization.","volume":"25","author":"Chien","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.4.421_bib6","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0006-291X(92)91130-I","article-title":"Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptor.","volume":"188","author":"Daujat","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.31.4.421_bib7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0016-5085(90)90963-2","article-title":"Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450.","volume":"99","author":"Diaz","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.31.4.421_bib8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1365-2125.1999.00043.x","article-title":"Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophylline.","volume":"48","author":"Dilger","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.31.4.421_bib9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0090-9556(25)06619-X","article-title":"Effect of model inducers on cytochrome P450 activities of human hepatocytes in primary culture.","volume":"23","author":"Donato","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.4.421_bib10","first-page":"1499","article-title":"Use of a reporter gene assay to predict and rank the potency and efficacy of CYP3A4 inducers.","volume":"29","author":"El-Sankary","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.4.421_bib11","first-page":"242","article-title":"Induction of CYP2C genes in human hepatocytes in primary culture.","volume":"29","author":"Gerbal-Chaloin","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.4.421_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00008571-199906000-00004","article-title":"Human CYP2B6: expression, inducibility and catalytic activities.","volume":"9","author":"Gervot","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.31.4.421_bib13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0090-9556(24)15217-8","article-title":"Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)- and (S)-ifosfamide in human liver microsomes.","volume":"27","author":"Granvil","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.4.421_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/abbi.2000.1708","article-title":"Expression of human cytochrome P450 2B6 in Escherichia coli: characterization of catalytic activity and expression levels in human liver.","volume":"376","author":"Hanna","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.31.4.421_bib15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/oxfordjournals.jbchem.a123619","article-title":"Genetic polymorphisms in the 5\u2032-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene.","volume":"110","author":"Hayashi","year":"1991","journal-title":"J Biochem (Tokyo)"},{"key":"10.1124\/dmd.31.4.421_bib16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0165-6147(99)01363-2","article-title":"Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment.","volume":"20","author":"Ingelman-Sundberg","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/dmd.31.4.421_bib17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s002040000151","article-title":"Characterization of liver microsomal 7-ethoxycoumarin O-deethylation and chlorzoxazone 6-hydroxylation activities in Japanese and Caucasian subjects genotyped for CYP2E1 gene.","volume":"74","author":"Inoue","year":"2000","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.31.4.421_bib18","series-title":"Metabolic Drug Interactions","first-page":"690","article-title":"Drugs as inducers of metabolic enzymes: rifampin, dexamethasone and omeprazole","author":"Jang","year":"2000"},{"key":"10.1124\/dmd.31.4.421_bib19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0026-895X(25)13617-1","article-title":"Expression of multiple forms of cytochrome P450 mRNAs in primary cultures of rat hepatocytes maintained on matrigel.","volume":"43","author":"Kocarek","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.31.4.421_bib20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/abbi.2000.1704","article-title":"Post-transcriptional regulation of rat CYP2E1 expression: role of CYP2E1 mRNA untranslated regions in control of translational efficiency and message stability.","volume":"376","author":"Kocarek","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.31.4.421_bib21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/bies.950120906","article-title":"Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIE1.","volume":"12","author":"Koop","year":"1990","journal-title":"Bioessays"},{"key":"10.1124\/dmd.31.4.421_bib22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0090-9556(24)15238-5","article-title":"The use of human hepatocyte cultures to study the induction of cytochrome P-450.","volume":"27","author":"Kostrubsky","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.4.421_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0091-6749(78)90068-4","article-title":"Effect of phenobarbital on theophylline disposition.","volume":"62","author":"Landay","year":"1978","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/dmd.31.4.421_bib24","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0090-9556(24)15241-5","article-title":"Influence of extracellular matrix overlay and medium formulation on the induction of cytochrome P-450 2B enzymes in primary cultures of rat hepatocytes.","volume":"27","author":"LeCluyse","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.4.421_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/(SICI)1099-0461(2000)14:4<177::AID-JBT1>3.0.CO;2-4","article-title":"Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes.","volume":"14","author":"LeCluyse","year":"2000","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1124\/dmd.31.4.421_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-4899-1863-5_9","article-title":"Cultured rat hepatocytes.","volume":"8","author":"LeCluyse","year":"1996","journal-title":"Pharm Biotechnol"},{"key":"10.1124\/dmd.31.4.421_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0009-2797(97)00071-9","article-title":"Primary human hepatocytes as a tool for the evaluation of structure- activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin.","volume":"107","author":"Li","year":"1997","journal-title":"Chem-Biol Interact"},{"key":"10.1124\/dmd.31.4.421_bib28","series-title":"Drug-Drug Interactions. Drugs and the Pharmaceutical Sciences","first-page":"217","article-title":"In vitro approaches for studying the inhibition of drug-metabolizing enzymes and identifying the drug-metabolizing enzymes responsible for the metabolism of drugs","author":"Madan","year":"2002"},{"key":"10.1124\/dmd.31.4.421_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0090-9556(24)14907-0","article-title":"Effect of cryopreservation on cytochrome P-450 enzyme induction in cultured rat hepatocytes.","volume":"27","author":"Madan","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.4.421_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0009-2797(97)00073-2","article-title":"Quantitative reverse transcriptase\/PCR assay for the measurement of induction in cultured hepatocytes.","volume":"107","author":"Mattes","year":"1997","journal-title":"Chem-Biol Interact"},{"key":"10.1124\/dmd.31.4.421_bib31","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1096\/fasebj.6.2.1371482","article-title":"Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture.","volume":"6","author":"Maurice","year":"1992","journal-title":"FASEB J"},{"key":"10.1124\/dmd.31.4.421_bib32","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/004982500406426","article-title":"Expression and induction of CYP1A1\/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: a 10-year follow-up.","volume":"30","author":"Meunier","year":"2000","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.31.4.421_bib33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1432-1033.1990.tb19140.x","article-title":"Expression of cytochrome P-450 enzymes in cultured human hepatocytes.","volume":"191","author":"Morel","year":"1990","journal-title":"Eur J Biochem"},{"key":"10.1124\/dmd.31.4.421_bib34","series-title":"Toxicology: The Basic Science of Poisons","first-page":"133","article-title":"Biotransformation of Xenobiotics","author":"Parkinson","year":"2001"},{"key":"10.1124\/dmd.31.4.421_bib35","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.1046\/j.0014-2956.2001.02540.x","article-title":"Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor.","volume":"268","author":"Pascussi","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1124\/dmd.31.4.421_bib36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0090-9556(25)08600-3","article-title":"Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.","volume":"18","author":"Pichard","year":"1990","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.4.421_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0090-9556(24)15002-7","article-title":"Human hepatocytes in primary culture predict lack of cytochrome P-450 3A4 induction by eletriptan in vivo.","volume":"28","author":"Pichard-Garcia","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.4.421_bib38","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.1016\/S0021-9258(17)37466-5","article-title":"The human CYP1A2 gene and induction by 3-methylcholanthrene. A region of DNA that supports AH-receptor binding and promoter-specific induction.","volume":"269","author":"Quattrochi","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.31.4.421_bib39","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0022-3565(24)29202-8","article-title":"Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays.","volume":"299","author":"Rae","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.31.4.421_bib40","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1124\/jpet.102.038653","article-title":"A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system.","volume":"303","author":"Raucy","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.31.4.421_bib41","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1124\/jpet.102.033837","article-title":"Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes.","volume":"302","author":"Raucy","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.31.4.421_bib42","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0090-9556(24)15146-X","article-title":"In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil.","volume":"28","author":"Robertson","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.4.421_bib43","first-page":"1204","article-title":"Specific and dose-dependent enzyme induction by omeprazole in human beings.","volume":"20","author":"Rost","year":"1994","journal-title":"Hepatology"},{"key":"10.1124\/dmd.31.4.421_bib44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/bbrc.2000.2902","article-title":"Induction of cytochrome P450 (CYP)1A1, CYP1A2 and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes.","volume":"273","author":"Runge","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.31.4.421_bib45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/004982500237668","article-title":"Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes.","volume":"30","author":"Sahi","year":"2000","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.31.4.421_bib46","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0026-895X(24)12760-5","article-title":"Molecular mechanisms of cytochrome P-450 induction by xenobiotics: an expanded role for nuclear hormone receptors.","volume":"56","author":"Savas","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.31.4.421_bib47","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/hep.1840180535","article-title":"Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes.","volume":"18","author":"Schuetz","year":"1993","journal-title":"Hepatology"},{"key":"10.1124\/dmd.31.4.421_bib48","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/S0021-9258(17)43507-1","volume":"259","author":"Schuetz","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.31.4.421_bib49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1124\/mol.62.3.439","article-title":"Development of a real-time in vivo transcription assay: application reveals pregnane X receptor-mediated induction of CYP3A4 by cancer chemotherapeutic agents.","volume":"62","author":"Schuetz","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.31.4.421_bib50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/096032719901800206","article-title":"Species differences in hepatocyte induction of CYP1A1 and CYP1A2 by omeprazole.","volume":"18","author":"Shih","year":"1999","journal-title":"Hum Exp Toxicol"},{"key":"10.1124\/dmd.31.4.421_bib51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0009-2797(99)00090-3","article-title":"Induction of cytochrome-P450 in cryopreserved rat and human hepatocytes.","volume":"121","author":"Silva","year":"1999","journal-title":"Chem-Biol Interact"},{"key":"10.1124\/dmd.31.4.421_bib52","first-page":"490","article-title":"Refinement of an in vitro cell model for cytochrome P450 induction.","volume":"26","author":"Silva","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.4.421_bib53","series-title":"Drug-Drug Interactions. Drugs and the Pharmaceutical Sciences","first-page":"217","article-title":"In vitro models for studying induction of cytochrome P450 enzymes","author":"Silva","year":"2001"},{"key":"10.1124\/dmd.31.4.421_bib54","doi-asserted-by":"crossref","first-page":"12822","DOI":"10.1074\/jbc.M005930200","article-title":"Orphan receptor promiscuity in the induction of cytochromes p450 by xenobiotics.","volume":"276","author":"Smirlis","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.31.4.421_bib55","doi-asserted-by":"crossref","first-page":"16689","DOI":"10.1016\/S0021-9258(18)66620-7","article-title":"Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s. Transcriptional and post-transcriptional regulation of the rat enzyme.","volume":"261","author":"Song","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.31.4.421_bib56","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0168-8278(95)80259-2","article-title":"Extracellular matrix proteins modulate cytochrome P450 2D6 expression in human hepatocytes.","volume":"22","author":"Trautwein","year":"1995","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.31.4.421_bib57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/abbi.1999.1351","article-title":"P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR and PPAR.","volume":"369","author":"Waxman","year":"1999","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.31.4.421_bib58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/bj2710113","article-title":"Phenobarbital induction of cytochromes P450: high level long-term responsiveness of primary rat hepatocyte cultures to drug induction and glucocorticoid dependence of the phenobarbital response.","volume":"271","author":"Waxman","year":"1990","journal-title":"Biochem J"},{"key":"10.1124\/dmd.31.4.421_bib59","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0168-8278(95)80263-0","article-title":"The influence of rifampin treatment on caffeine clearance in healthy man.","volume":"22","author":"Wietholtz","year":"1995","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.31.4.421_bib60","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1101\/gad.846800","article-title":"Reciprocal activation of xenobiotic response genes by nuclear receptors SXR\/PXR and CAR.","volume":"14","author":"Xie","year":"2000","journal-title":"Genes Dev"},{"key":"10.1124\/dmd.31.4.421_bib61","doi-asserted-by":"crossref","first-page":"37739","DOI":"10.1074\/jbc.R100033200","article-title":"Orphan nuclear receptors: the exotics of xenobiotics.","volume":"276","author":"Xie","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.31.4.421_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/abbi.1997.0571","article-title":"Posttranslational elevation of cytochrome P450 3A levels and activity by dimethyl sulfoxide.","volume":"353","author":"Zangar","year":"1998","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.31.4.421_bib63","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0090-9556(24)15127-6","article-title":"Dexamethasone differentially regulates expression of carboxylesterase genes in humans and rats.","volume":"28","author":"Zhu","year":"2000","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624026461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624026461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.31.4.421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T15:10:37Z","timestamp":1739891437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624026461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["S0090955624026461"],"URL":"https:\/\/doi.org\/10.1124\/dmd.31.4.421","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Prototypical Microsomal Enzyme Inducers on Cytochrome P450 Expression in Cultured Human Hepatocytes","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.31.4.421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}